BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 1987376)

  • 1. Complementation between avirulent Newcastle disease virus and a fusion protein gene expressed from a retrovirus vector: requirements for membrane fusion.
    Morrison T; McQuain C; McGinnes L
    J Virol; 1991 Feb; 65(2):813-22. PubMed ID: 1987376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Avian cells expressing the Newcastle disease virus hemagglutinin-neuraminidase protein are resistant to Newcastle disease virus infection.
    Morrison TG; McGinnes LW
    Virology; 1989 Jul; 171(1):10-7. PubMed ID: 2545025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Newcastle disease virus envelope glycoproteins expressed in insect cells.
    Murakami Y; Kagino T; Niikura M; Mikami T; Ishii K; Matsuura Y
    Virus Res; 1994 Aug; 33(2):123-37. PubMed ID: 7975877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hemagglutinin-neuraminidase protein of Newcastle disease virus determines tropism and virulence.
    Huang Z; Panda A; Elankumaran S; Govindarajan D; Rockemann DD; Samal SK
    J Virol; 2004 Apr; 78(8):4176-84. PubMed ID: 15047833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleotide sequence of the fusion and haemagglutinin-neuraminidase glycoprotein genes of Newcastle disease virus, strain Ulster: molecular basis for variations in pathogenicity between strains.
    Millar NS; Chambers P; Emmerson PT
    J Gen Virol; 1988 Mar; 69 ( Pt 3)():613-20. PubMed ID: 3351479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avian adeno-associated virus-based expression of Newcastle disease virus hemagglutinin-neuraminidase protein for poultry vaccination.
    Perozo F; Villegas P; Estevez C; Alvarado IR; Purvis LB; Saume E
    Avian Dis; 2008 Jun; 52(2):253-9. PubMed ID: 18646454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of host selective pressure on Newcastle disease virus virulence.
    Zanetti F; Berinstein A; Carrillo E
    Microb Pathog; 2008 Feb; 44(2):135-40. PubMed ID: 17900851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing environmental safety and cell-killing potential of oncolytic Newcastle Disease virus with modifications of the V, F and HN genes.
    de Graaf JF; van Nieuwkoop S; Bestebroer T; Groeneveld D; van Eijck CHJ; Fouchier RAM; van den Hoogen BG
    PLoS One; 2022; 17(2):e0263707. PubMed ID: 35139115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Construction and characterization of a recombinant fowlpox virus co-expressing F, HN genes of Newcastle disease virus and gB gene of infectious laryngnotracheitis virus].
    Sun HL; Wang YF; Miao DY; Zhang PJ; Zhi HD; Xu LL; Wang M; Tong GZ; Wang M
    Sheng Wu Gong Cheng Xue Bao; 2006 Nov; 22(6):931-9. PubMed ID: 17168315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of the length of the HN protein and the sequence of the F protein cleavage site to Newcastle disease virus pathogenicity.
    Römer-Oberdörfer A; Werner O; Veits J; Mebatsion T; Mettenleiter TC
    J Gen Virol; 2003 Nov; 84(Pt 11):3121-3129. PubMed ID: 14573818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High cell surface expression of Newcastle disease virus proteins via replicon vectors demonstrates syncytia forming activity of F and fusion promotion activity of HN molecules.
    Zeng J; Fournier P; Schirrmacher V
    Int J Oncol; 2004 Aug; 25(2):293-302. PubMed ID: 15254725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syncytia generated by hemagglutinin-neuraminidase and fusion proteins of virulent Newcastle disease virus induce complete autophagy by activating AMPK-mTORC1-ULK1 signaling>.
    Ren S; Rehman ZU; Shi M; Yang B; Qu Y; Yang XF; Shao Q; Meng C; Yang Z; Gao X; Sun Y; Ding C
    Vet Microbiol; 2019 Mar; 230():283-290. PubMed ID: 30658866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The attachment function of the Newcastle disease virus hemagglutinin-neuraminidase protein can be separated from fusion promotion by mutation.
    Sergel T; McGinnes LW; Peeples ME; Morrison TG
    Virology; 1993 Apr; 193(2):717-26. PubMed ID: 8384752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reverse Genetics for Newcastle Disease Virus as a Vaccine Vector.
    Kim SH; Samal SK
    Curr Protoc Microbiol; 2018 Feb; 48():18.5.1-18.5.12. PubMed ID: 29512119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newcastle Disease Virus Establishes Persistent Infection in Tumor Cells
    Rangaswamy US; Wang W; Cheng X; McTamney P; Carroll D; Jin H
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28592535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemagglutinin-Neuraminidase and fusion genes are determinants of NDV thermostability.
    Liu T; Song Y; Yang Y; Bu Y; Cheng J; Zhang G; Xue J
    Vet Microbiol; 2019 Jan; 228():53-60. PubMed ID: 30593380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of a recombinant chimeric Newcastle disease virus vaccine that allows serological differentiation between vaccinated and infected animals.
    Peeters BP; de Leeuw OS; Verstegen I; Koch G; Gielkens AL
    Vaccine; 2001 Feb; 19(13-14):1616-27. PubMed ID: 11166884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of individual glycoproteins of Newcastle disease virus expressed in insect cells: the fusion protein derived from an avirulent strain had lower protective efficacy.
    Kamiya N; Niikura M; Ono M; Kai C; Matsuura Y; Mikami T
    Virus Res; 1994 Jun; 32(3):373-9. PubMed ID: 8079517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of pathotype-specific structural features and cleavage activation of Newcastle disease virus membrane glycoproteins using antipeptide antibodies.
    Hodder AN; Selleck PW; White JR; Gorman JJ
    J Gen Virol; 1993 Jun; 74 ( Pt 6)():1081-91. PubMed ID: 8509761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleotide sequence of the envelope protein genes of a highly virulent, neurotropic strain of Newcastle disease virus.
    Schaper UM; Fuller FJ; Ward MD; Mehrotra Y; Stone HO; Stripp BR; De Buysscher EV
    Virology; 1988 Jul; 165(1):291-5. PubMed ID: 3388773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.